Life sciences tools Analytical Instruments segment income margin measures segment income as a percentage of segment revenue under Thermo Fisher Scientific's management reporting definition.
Thermo Fisher reported a 23.0% Analytical Instruments segment income margin in the second quarter of 2026, up from 18.8% a year earlier.
Productivity and volume leverage widened the margin
Thermo Fisher attributed the improvement primarily to very strong productivity, favorable volume leverage, and foreign exchange.
That makes the margin a conversion measure rather than a direct read on instrument pricing or unit demand.
Segment income is an issuer-defined operating measure
Thermo Fisher evaluates segment performance using operating income before specified charges and credits. The measure should not be treated as a standardized peer operating margin.
Read it with Analytical Instruments organic revenue growth and Specialty Diagnostics segment income margin.
Primary source: Thermo Fisher Scientific Q2 2026 Form 10-Q.
Part of the Life Sciences Tools & Biopharma Services Economics
See It in Company Research
These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.
- TMOOpen operating-model research →10 of 10 reviewed concepts in Life Sciences Tools & Biopharma Services EconomicsSegment income conversion4 of 4 bridge concepts supportedContinue through this bridge:Lab Products & Biopharma MarginLife Sciences Solutions MarginSpecialty Diagnostics Margin
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare analytical instrument margins
Compare segment-income conversion with volume leverage, productivity, currency, and issuer cost definitions preserved.
Explore more topics in the Financial Research Encyclopedia.